CaNCURE is a partnership between Northeastern University and
Dana-Farber / Harvard Cancer Center funded by the National Cancer Institute.
Wednesday, January 10, 2018 12:00 PM
This orientation will provide our new trainees with an introduction to cancer nanomedicine research, responsible conduct in research, and expectations of the CaNCURE program.
Wednesday, December 13, 2017 12:00 PM
Our third annual CaNCURE Co-op Showcase will feature talks and posters by the 2017 CaNCURE co-op students, all of whom have performed cutting edge nanomedicine research in laboratories across Boston. We invite all faculty and students to join us on Dec 13 at Noon to celebrate the accomplishments of our Nanomedicine trainees! No registration is necessary […]
Friday, December 1, 2017 3:25 PM
Dr. Thomas Webster
Professor and Chair, Department of Chemical Engineering, Northeastern University
Thursday, November 30, 2017 2:50 PM
Ambika Bajpayee, Ph.D.
Assistant Professor, Department of Bioengineering, Northeastern University
Wednesday, November 22, 2017 3:00 PM
A research poster is a visual communication tool that allows you to describe and share your research in a concise graphic format. It can attract attention, convey information clearly, and initiate conversations at any stage of the research process. Researchers often create posters before the completion of the research project in order to invite feedback […]
Friday, November 17, 2017 3:25 PM
Sunil Krishnan, M.D., FACP,
Professor, Department of Radiation Oncology, University of Texas MD Anderson Cancer Center
Friday, November 10, 2017 3:25 PM
Dr. Zdravka Medarova Associate Professor in Radiology, Harvard Medical School Progress Towards Rational Cancer Therapy Over 90% of deaths from cancer are, in fact, due to metastasis and not the primary tumor. However, development of cancer therapeutics is traditionally focused on the primary tumor, which is partly the reason behind the poor outcomes in […]
Thursday, November 9, 2017 2:50 PM
Brian Polizzotti, Ph.D.
Assistant Professor of Pediatrics, Harvard Medical School
Friday, November 3, 2017 3:25 PM
Karen Liby, Ph.D. Associate Professor at Pharmacology & Toxicology, Michigan State University Despite tremendous progress in our understanding of the biology of cancer, the translation of these advances into a clinical benefit has not kept pace, as the number of deaths from cancer remain unacceptably high. However, rapid advancements in nanomedicine provide opportunities to […]
Friday, October 27, 2017 3:25 PM
Jon Dobson, Ph.D. J. Crayton Pruitt Family Department of Biomedical Engineering & Department of Materials Science and Engineering, University of Florida The use of magnetic micro‐ and nanoparticles for biomedical applications was first proposed in the 1920s as a way to measure the rheological properties of the cytoplasm. Since that time, particle synthesis techniques and […]